Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market To Be Driven By The Growing Need To Treat Conditions Of Respiratory Failure In The Forecast Period Of 2022-2027

Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market

The new report by Expert Market Research titled, ‘Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market Report and Forecast 2022-2027’, gives an in-depth analysis of the global extracorporeal carbon dioxide removal (ECCO2R) devices market size, assessing the market based on its segments like products, accesses, end-uses, applications, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.

Request a free sample copy in PDF or view the report [email protected]

The key highlights of the report include:

Market Overview (2017-2027)

• Forecast CAGR (2022-2027): 6.9%

The rise in acute respiratory distress syndrome (ARDS) and chronic obstructive pulmonary disease (COPD) has led to the introduction of novel products for vitalising blood flow and efficient gas exchange, propelling the market growth. An increase in chronic respiratory diseases is expected to drive the demand for extracorporeal CO2 removal devices. Also, the rising preference for safe and rapid minimally invasive ventilation devices is accelerating the market growth. During the COVID-19 pandemic, a rising number of regulatory product approvals for different extracorporeal removal devices aided several market players in increasing their product sales. The presence of a large patient pool, expanding awareness of acute respiratory failure, and rising government healthcare expenditure in developing nations, such as Japan and India, are expected to drive the regional market expansion.

Industry Definition and Major Segments

Extracorporeal carbon dioxide eliminates increased carbon dioxide levels caused by respiratory failure. It entails inserting a dialysis catheter-like tube into a big vein. The blood is pushed through a machine and the carbon dioxide is removed.

By product, the market is classified into:

• Disposables
• Extracorporeal CO2 Machines
• Others

Based on access, the market is segmented into:

• Venovenous
• Arteriovenous

The end-uses of the market include the following:

• Ambulatory Surgical Centres
• Hospitals
• Clinics
• Others

The major applications of the market are:

• Chronic Obstructive Pulmonary Disease (COPD)
• Bridge to Lung Transplant
• Acute Respiratory Distress Syndrome (ARDS)
• Others

On the basis of region, the market is segmented into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Market Trends

Several technological advancements and techniques have enabled the complexity and size of extracorporeal CO2 removal devices to be reduced in recent years. Numerous technological advances have made extracorporeal CO2 removal devices possible and easy to operate. Thus, technological advancements are expected to fuel the market growth. Due to the large population base and low per capita income, there is a great demand for economical treatment solutions. As a result, international corporations are eager to invest in developing countries, such as China, anticipating regional market expansion. Favourable reimbursement policies, increasing government investments in long-term healthcare, the success rate of extracorporeal CO2 removal devices during respiratory surgeries, and growing healthcare research infrastructural framework are also driving the market growth.

Key Market Players

The major players in the market including Baxter International, Inc., Aferetica s.r.l., Getinge AB, XENIOS AG, and Estor SpA, among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

About Us:

Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.

EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.

Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.

Media Contact

Company Name: Claight Corporation
Contact Person: Ana John, Corporate Sales Specialist – U.S.A.
Email: [email protected]
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.


Please enter your comment!
Please enter your name here